Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001562180-18-001976)

Filing Details

Accession Number:: 0001562180-18-001976
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-04-25 19:21:15
Reporting Period:: 2018-04-23

Accepted Time:: 2018-04-25 19:21:15
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1656328	Sienna Biopharmaceuticals Inc.	SNNA	Pharmaceutical Preparations (2834)	273364627

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1711463	Todd Harris	C/O Sienna Biopharmaceuticals, Inc. 30699 Russell Ranch Road, Suite 140 Westlake Village CA 91362	Head Of Corporate Development	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2018-04-23	525	$20.00	571,541	No	4	S	Direct
Common Stock	Disposition	2018-04-24	150	$20.00	571,391	No	4	S	Direct
Common Stock	Disposition	2018-04-25	300	$20.00	571,091	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 22, 2017.